Mohamed Elshenawy - 12 May 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Chief Technology Officer
Signature: /s/ Scott Paraker, Attorney-in-Fact for Mohamed Elshenawy
Issuer symbol: HIMS
Transactions as of: 12 May 2025
Net transactions value: $0
Form type: 4
Filing time: 14 May 2025, 21:49:34 UTC
Previous filing: 14 May 2025
Next filing: 24 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Elshenawy Mohamed	Chief Technology Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO	/s/ Scott Paraker, Attorney-in-Fact for Mohamed Elshenawy	14 May 2025	0002068597

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HIMS	Restricted Stock Unit	Award	$0	+1,036,339		$0.000000	1,036,339	12 May 2025	Class A Common Stock	1,036,339		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2	The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on June 15, 2026, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments thereafter on the specified vesting dates of March 15, June 15, September 15, and December 15 (each, a "Company Quarterly Vesting Date").